AMMONAPS

This brand name is authorized in Austria, Estonia, Finland, France, Ireland, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug AMMONAPS contains one active pharmaceutical ingredient (API):

1	Sodium phenylbutyrate UNII NT6K61736T - SODIUM PHENYLBUTYRATE
	Sodium phenylbutyrate is a pro-drug and is rapidly metabolised to phenylacetate. Phenylacetate is a metabolically active compound that conjugates with glutamine via acetylation to form phenylacetylglutamine which is then excreted by the kidneys. On a molar basis, phenylacetylglutamine is comparable to urea (each containing 2 moles of nitrogen) and therefore provides an alternate vehicle for waste nitrogen excretion.
	Read more about Sodium phenylbutyrate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AMMONAPS Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AX03	Sodium phenylbutyrate	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AX Various alimentary tract and metabolism products
Discover more medicines within A16AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1201521, 1201532, 1201543, 1201554
ES	Centro de información online de medicamentos de la AEMPS	99120001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	431801, 585393
FR	Base de données publique des médicaments	60052254, 61128922
GB	Medicines & Healthcare Products Regulatory Agency	48916
IE	Health Products Regulatory Authority	88238
LT	Valstybinė vaistų kontrolės tarnyba	1027370, 1027371, 1027372, 1027373
NL	Z-Index G-Standaard, PRK	93866
PL	Rejestru Produktów Leczniczych	100161869, 100161875
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66278001, W66278002, W66279001, W66279002